India grants approval for domestic manufacture of neural implants under new medical device policy

Summary

India's Central Drugs Standard Control Organisation issued new guidelines permitting domestic manufacture of Class C neural implants under an expedited approval pathway, cutting typical device review timelines from 5 years to 18 months. Three Indian startups have already applied under the new framework targeting DBS and cochlear implant manufacturing.